lenalidomide has been researched along with Plasmablastic Diffuse Large B-cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kodad, SG; Sabry, W; Wu, Y | 1 |
| Ando, K; Hata, T; Hourai, M; Imaizumi, Y; Kobayashi, Y; Miyazaki, Y; Niino, D; Ohshima, K; Sato, S; Sawayama, Y | 1 |
| Cheng, L; Cheng, S; Liu, M; Qian, Y; Song, Q; Wang, C; Wang, L; Wang, Y; Xu, P; Yi, H; Zhao, W | 1 |
| Cabanillas, F; Castillo, C; Cruz-Chacón, A; Marrero, WD | 1 |
| Cahn, JY; Carras, S; Gervasoni, J; Gressin, R; Molina, L; Peoc'h, M; Regny, C | 1 |
| Jain, N; Malhotra, P; Prakash, G; Sahu, KK; Saikia, U; Yanamandra, U | 1 |
| Birkmann, J; Kalisch, A; Pretscher, D; Wilhelm, M | 1 |
| DeLaune, J; Grosbach, A; Norkin, M; Schmit, JM | 1 |
1 review(s) available for lenalidomide and Plasmablastic Diffuse Large B-cell Lymphoma
| Article | Year |
|---|---|
Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Drug Resistance, Neoplasm; Humans; Immunoconjugates; Lenalidomide; Male; Plasmablastic Lymphoma; Prognosis; Thalidomide; Treatment Outcome | 2017 |
7 other study(ies) available for lenalidomide and Plasmablastic Diffuse Large B-cell Lymphoma
| Article | Year |
|---|---|
Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
Topics: Bortezomib; Dexamethasone; HIV Infections; Humans; Lenalidomide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma | 2022 |
Bortezomib- and Lenalidomide-Based Treatment of Refractory Plasmablastic Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Drug Resistance, Neoplasm; Humans; Lenalidomide; Male; Middle Aged; Neoplasm Recurrence, Local; Plasmablastic Lymphoma; Prognosis; Remission Induction; Salvage Therapy | 2020 |
Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lenalidomide; Plasmablastic Lymphoma | 2021 |
Successful Use of Bortezomib-Lenalidomide Combination as Treatment for a Patient With Plasmablastic Lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Bortezomib; Female; Humans; Lenalidomide; Plasmablastic Lymphoma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma.
Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Lenalidomide; Male; Plasmablastic Lymphoma; Retreatment; Stomach Neoplasms; Thalidomide; Treatment Outcome | 2015 |
Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lenalidomide; Lymphoma, AIDS-Related; Maxillary Sinus Neoplasms; Plasmablastic Lymphoma; Poverty; Prednisolone; Remission Induction; Thalidomide; Vincristine | 2016 |
A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Computed Tomography Angiography; Cyclophosphamide; Dexamethasone; Epstein-Barr Virus Infections; HIV Seronegativity; Humans; Lenalidomide; Male; Plasmablastic Lymphoma; Prognosis; Remission Induction; Sigmoid Neoplasms; Thalidomide | 2017 |